SCHEMBL7723993

SCHEMBL7723993

O=C(NC1CCN(CCc2ccc(Br)cc2)C1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
HSD11B1 P28845 1/20 0.46
EPHX1 P07099 2/20 0.46
RAB9A P51151 1/20 0.46
SIGMAR1 Q99720 2/20 0.44
P2RX7 Q99572 1/20 0.43
FKBP1A P62942 1/20 0.43
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
HTR2A P28223 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
XIAP P98170 1/20 0.41
BIRC2 Q13490 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7723988 1.00 KMT2A (0.47) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7719868 0.90 HSD11B1 (0.59) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7729574 0.90 HSD11B1 (0.59) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7719871 0.90 HSD11B1 (0.59) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7724337 0.89 KMT2A (0.51) KMT2AHSD11B1EPHX1RAB9AP2RX7
SCHEMBL7724326 0.89 CXCR3 (0.52) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7719734 0.89 KMT2A (0.51) KMT2AHSD11B1EPHX1RAB9AP2RX7
SCHEMBL7724323 0.89 CXCR3 (0.52) KMT2AHSD11B1EPHX1RAB9ASIGMAR1
SCHEMBL7719729 0.89 KMT2A (0.51) KMT2AHSD11B1EPHX1RAB9AP2RX7
Hydrochloric Acid SCHEMBL7719915 0.87 KMT2A (0.49) KMT2AHSD11B1EPHX1RAB9AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed